Head-To-Head Comparison: DSV (OTCMKTS:DSDVY) versus CryoPort (NASDAQ:CYRX)

DSV (OTCMKTS:DSDVY) and CryoPort (NASDAQ:CYRX) are both transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings for DSV and CryoPort, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DSV	1	1	1	2	2.80
CryoPort	1	1	8	1	2.82

CryoPort has a consensus target price of $12.56, indicating a potential upside of 24.81%. Given CryoPort’s stronger consensus rating and higher possible upside, analysts plainly believe CryoPort is more favorable than DSV.

Insider & Institutional Ownership

0.2% of DSV shares are held by institutional investors. Comparatively, 92.9% of CryoPort shares are held by institutional investors. 10.0% of CryoPort shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares DSV and CryoPort’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DSV	5.29%	11.89%	5.67%
CryoPort	37.21%	-9.79%	-5.42%

Earnings and Valuation

This table compares DSV and CryoPort”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DSV	$24.24 billion	2.01	$1.47 billion	$3.26	31.15
CryoPort	$228.38 million	2.21	-$114.76 million	$1.33	7.56

DSV has higher revenue and earnings than CryoPort. CryoPort is trading at a lower price-to-earnings ratio than DSV, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

DSV has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500.

Summary

CryoPort beats DSV on 8 of the 15 factors compared between the two stocks.

About DSV

DSV A/S offers transport and logistics services in Europe, the Middle East, Africa, North America, South America, Asia, Australia, and the Pacific. It operates through three segments: Air & Sea, Road, and Solutions. The company provides air freight, air freight compliance and carrier, and rail freight services; sea freight, and sea freight compliance and carrier services, as well as freight containers. It also offers road freight services, such as part and full loads, groupage, specialized transport, express, and online and document handling services; and workshops. In addition, the company provides logistics solutions for automotive, technology, healthcare, energy, industrial, retail/ fashion, and chemical sectors; and inventory management solutions. Further, it offers special project transport services, such as industrial projects, renewable energy, government logistics, ship charter, and air charter services; and courier and warehousing services. The company was formerly known as DSV Panalpina A/S and changed its name to DSV A/S in September 2021. DSV A/S was incorporated in 1976 and is based in Hedehusene, Denmark.

About CryoPort

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.